Long term Failure of endoscopic gastroplication (EndoCinch)

Schiefke, I.; Zabel-Langhennig, A.; Neumann, S.; Feisthammel, J.; Moessner, J.; Caca, K.
June 2005
Gut;Jun2005, Vol. 54 Issue 6, p752
Academic Journal
Introduction: Endoluminal gastroplication (EndoCinch; Bard) has been introduced as an endoscopic treatment option in gastro-oesophageal reflux disease (GORD) patients with promising short term results. However, little is known about the long term efficacy of endoscopic suturing. The aim of this study was to evaluate prospectively the long term outcome after EndoCinch. Patients and methods: A total of 70 patients treated with EndoCinch at a single referral centre were studied prospectively. All patients were interviewed using a standardised questionnaire regarding their symptoms and medication prior to and 18 months after EndoCinch. In addition, follow up included endoscopy, 24 hour pH monitoring, and oesophageal manometry. Results: The procedure was well tolerated without major short or long term complications. Eighteen months after EndoCinch, 56/70 patients (80%) were considered treatment failures as their heartburn symptoms did not improve or proton pump inhibitor medication exceeded 50% of the initial dose. Endoscopy showed all sutures in situ in 12/70 (17%) patients while no remaining sutures could be detected in 18/70(26%). In 54 and 50 patients examined, respectively, no significant changes in 24 hour pH monitoring (median pH <4/24 hours, 9.1 % v 8.5%; p = 0.82) or lower oesophageal sphincter (LOS) pressure (7.7 v 10.3 mm Hg; p=0.051) were observed while median LOS length slightly increased (3.0 to 3.2 cm; p<0.05). Conclusion: Endoscopic gastroplication (EndoCinch) is a safe and minimally invasive endoscopic treatment for GORD with reasonable short term results. In contrast, long term outcome is disappointing, probably due to suture loss in the majority of patients. Therefore, technical improvements to ensure suture durability are mandatory before endoscopic suturing can evolve as a therapeutic option for GORD treatment.


Related Articles

  • Test for GERD Reveals That Many Are Taking Medications Unnecessarily.  // Women's Health Advisor;Sep2013, Vol. 17 Issue 9, p5 

    The article focuses on the increased inappropriate use of proton pump inhibitors (PPI) by people without being diagnosed with gastro esophageal reflux disease (GERD). It suggests for early diagnosis of GERD by esophageal power of hydrogen (Ph) monitoring following an endoscopy which helps to...

  • Proton-pump inhibitors pivotal for nocturnal gastro-oesophageal reflux disease in the elderly.  // Drugs & Therapy Perspectives;May2004, Vol. 20 Issue 5, p12 

    Elderly patients with nocturnal symptoms of gastro-oesophageal reflux disease (GORD) usually have a more aggressive and complicated disease course than younger patients. Early endoscopy of the upper gastrointestinal tract is important to differentiate between oesophageal mucosal injury and...

  • Refractory Gastro-Oesophageal Reflux Disease. Liu, Julia J.; Saltzman, John R. // Drugs;2009, Vol. 69 Issue 14, p1935 

    Refractory gastro-oesophageal reflux disease (GORD) is described when reflux symptoms have not responded to 4-8 weeks of proton pump inhibitor therapy and occurs in a heterogeneous mixture of patients. The causes of refractory GORD include inadequate acid suppression, non-acid gastrooesophageal...

  • Gastroesophageal Reflux Disease: Endoscopy, Duration of Treatment, and Choice of PPI. Greenspan, Neil R. // Medicine & Health Rhode Island;Apr2011, Vol. 94 Issue 4, p92 

    The article discusses the diagnosis and treatment of gastroesophageal reflux disease (GERD). It offers choices of Proton Pump Inhibitors (PPIs) that have been shown to be more efficacious in controlling acute symptoms and the most effective agents for healing esophagitis. It mentions that...

  • A Cost-Effectiveness Analysis of Prescribing Strategies in the Management of Gastroesophageal Reflux Disease. Gerson, Lauren B.; Robbins, Anthony S.; Garber, Alan; Hornberger, John; Triadafilopoulos, George // American Journal of Gastroenterology;Feb2000, Vol. 95 Issue 2, p395 

    OBJECTIVE: Patients who have uncomplicated gastroesophageal- reflux disease (GERD) typically present with heartburn and acid regurgitation. We sought to determine the cost-effectiveness of H2-receptor antagonists (H2RAs) and proton pump inhibitors (PPIs) as first-line empiric therapy for...

  • Esophageal Mucosal Breaks in Gastroesophageal Reflux Disease Partially Responsive to Proton Pump Inhibitor Therapy. Shaheen, Nicholas J; Denison, Hans; Björck, Karin; Silberg, Debra G // American Journal of Gastroenterology;Apr2013, Vol. 108 Issue 4, p529 

    OBJECTIVES:Approximately 20-30% of patients with gastroesophageal reflux disease (GERD) do not experience complete symptom resolution during proton pump inhibitor (PPI) therapy. The aim of this study was to determine the prevalence of esophageal mucosal breaks among patients who have a partial...

  • Diagnosis and Management of Gastroesophageal Reflux Disease (GERD): An Indian Perspective. PODDAR, UJJAL // Indian Pediatrics;Jan2013, Vol. 50 Issue 1, p119 

    Need and Purpose: The scarcity of literature and lack of published guidelines on gastroesophageal reflux disease (GERD) from India, have necessitated this review. Methods: A literature search in PubMed was conducted with regard to epidemiology, clinical features, investigation and management of...

  • DOES ENDOSCOPY ALTER MANAGEMENT FOR SIMPLE REFLUX DISEASE. Turner, G. B.; Tham, T. C. K. // Gut;Apr2004 Supplement 3, Vol. 53, pA10 

    The role of endoscopy for patients with simple gastro-oesophogeal reflux disease is unclear particularly under the age of 55 years. Authors report the influence of endoscopy on the management of 100 patients with uncomplicated reflux symptoms. Endoscopy for simple reflux symptoms led to a change...

  • Esophageal acid exposure still plays a major role in patients with NERD. Savarino, Edoardo; Zentilin, Patrizia; Savarino, Vincenzo // Journal of Gastroenterology;Apr2013, Vol. 48 Issue 4, p552 

    No abstract available.


Read the Article


Sign out of this library

Other Topics